Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab.
Ikegawa S, Meguri Y, Mizuhara K, Fukumi T, Kobayashi H, Sumii Y, Kondo T, Sando Y, Iwamoto M, Asada N, Ennishi D, Nishimori H, Fujii K, Fujii N, Fujisawa Y, Imai T, Maeda Y, Matsuoka KI.
Ikegawa S, et al. Among authors: imai t.
Leukemia. 2021 Mar;35(3):929-931. doi: 10.1038/s41375-021-01167-8. Epub 2021 Feb 17.
Leukemia. 2021.
PMID: 33597730
No abstract available.